COFAMOX 15 L.A.
AMOXICILLINE
About this veterinary medicine
COFAMOX 15 L.A. is a veterinary medicine in the form of suspension injectable containing amoxicilline. It is marketed by DOPHARMA FRANCE. It holds a marketing authorisation in Tunisia under number 1034.1522.22.
Characteristics
- Form
- Suspension injectable
- Strength
- 150 MG/ML
- Presentation
- Flacon de 100 ml
- Route of administration
- Injectable route
- Laboratory
- DOPHARMA FRANCE
- Country
- France
Regulatory status — Tunisie
🟢 Marketing authorisation in force
Authorisation no. : 1034.1522.22 — Authorisation date : 24/11/2022
⚠️ Regulatory alerts
No alert reported.
🔴 Batch recalls
No batch currently reported as recalled.
📦 Availability in Tunisia
Reported by TunisieVet veterinarians.
No availability information yet.
🔒 Availability reporting is reserved for signed-in veterinarians.
Sources
- dpm verified on 30/09/2026
Last synchronisation : 30/09/2026
Report availability
Sign in to your veterinarian account to report availability.
Log InOnly veterinarians can report availability.
TunisieVet in your pocket 📱🐾 Access your veterinary services wherever you are. [ Download the app ]
Learn more